Skip to Main Content

Paper Details

Phase II trial of bortezomib alone or in combination with irinotecan in patients with adenocarcinoma of the gastroesophageal junction or stomach.
Invest New Drugs
10
2014
Author NameAffiliation
Allyson J OceanWeill Cornell Medical College
  • 1 - 1

Datasets

Release 1.2